Views: 0 Author: Peter Cui Publish Time: 2026-05-24 Origin: Mitour Silicone
Table of Contents
TL;DR Patent CN113650314A covers a proprietary antimicrobial silicone composition developed by Mitour Silicone that incorporates inorganic antimicrobial agents — silver ion and zinc ion systems — into a platinum-cured silicone matrix, achieving greater than 99% bacterial reduction against Staphylococcus aureus and Escherichia coli per ISO 22196 testing. This article breaks down what the patent claims, how each antimicrobial mechanism works, why it matters specifically for pacifiers and teethers, and what buyers should ask before accepting any "antibacterial silicone" claim from a supplier.
Patent CN113650314A is a Chinese invention patent covering an antimicrobial silicone composition with specific loading ratios of silver ion or zinc ion carriers
ISO 22196 is the standard test method for measuring antibacterial activity on plastics and non-porous surfaces; a >99% bacterial reduction (3-log reduction) is the threshold for meaningful antimicrobial performance
Silver ions (Ag+) disrupt bacterial cell membranes and denature respiratory enzymes; zinc ions (Zn2+) disrupt cell wall synthesis at lower concentrations
The patent formulation is designed for infant-contact applications — the antimicrobial agent loading is calibrated to maintain efficacy while staying below migration limits for infant products under EN 71-3 and FDA 21 CFR 177.2600
Surface bacteria on pacifiers and teethers can reach 10^4–10^6 colony-forming units (CFU) within 30 minutes of contact with saliva in a non-sterile environment
Antibacterial silicone is an additional layer of protection — not a substitute for regular cleaning and sterilization
Patent CN113650314A, granted by the China National Intellectual Property Administration (CNIPA), describes a method for incorporating inorganic antimicrobial agents into a silicone rubber matrix to produce a compound with sustained, durable antibacterial properties.
The core innovation is the dispersion approach. Antimicrobial agents — specifically silver ion carriers (silver-zeolite or silver phosphate glass) and zinc ion carriers (zinc oxide nanoparticles or zinc-loaded silica) — have historically been difficult to homogenize in silicone because of the hydrophobic nature of the silicone matrix and the hydrophilic surface chemistry of the ionic particles. Uneven dispersion leads to "hot spots" with excess antimicrobial concentration alongside zones of negligible activity. Hot spots carry a dual risk: insufficient coverage in low-concentration zones, and potential ion leaching above regulatory limits in high-concentration zones.
The patent addresses this through a surface treatment step applied to the antimicrobial particle before compounding. The particle surface is compatibilized with a silane coupling agent — specifically a vinyl silane — that forms a covalent bond between the inorganic particle and the surrounding silicone polymer network during vulcanization. The result is a particle that is chemically anchored in place rather than physically dispersed, dramatically improving both homogeneity and durability of the antimicrobial effect through multiple sterilization cycles.
The patent claims specify performance: the antimicrobial silicone composition maintains >99% bacterial reduction (per ISO 22196) after 30 dishwasher sterilization cycles. Standard antimicrobial additives in silicone without surface treatment typically show declining efficacy after 10–15 wash cycles as particles migrate to the surface and are physically removed.
Understanding the mechanism helps you evaluate claims. A supplier who says "silver silicone" but cannot explain how the silver is stabilized or what ion release rate their compound achieves is selling you a marketing term, not a validated technology.
Silver ions attack bacteria through three concurrent pathways:
Pathway 1 — Cell membrane disruption: Ag+ binds to negatively charged phosphate groups in the bacterial cell membrane. This disrupts membrane integrity, causes ion leakage from the cell interior, and ultimately leads to cell lysis (rupture). This is the fastest-acting pathway; membrane disruption can be detected within minutes of exposure.
Pathway 2 — Respiratory enzyme inhibition: Inside the cell, Ag+ binds to thiol groups (-SH) on respiratory chain enzymes (particularly NADH dehydrogenase). This shuts down the cell's ability to generate ATP — the energy currency of life. Without ATP, cell maintenance and reproduction stop.
Pathway 3 — DNA binding: Ag+ intercalates with bacterial DNA, preventing replication. This is the mechanism that explains the bacteriostatic (growth-inhibiting) effect even at sub-lethal silver concentrations.
The minimum inhibitory concentration (MIC) of Ag+ for Staphylococcus aureus is approximately 0.1–0.5 ppm. For E. coli, it is 0.5–1.0 ppm. The CN113650314A composition is designed to deliver a surface-available Ag+ concentration consistently above these MIC values over the product lifetime.
The limitation of silver: at very high loading, Ag+ can cause surface discoloration (yellowing) in silicone. The patent's surface treatment approach minimizes this by reducing the required total loading while maintaining MIC-level surface availability.
Zinc ions operate through a different and complementary mechanism:
Primary action — Cell wall synthesis inhibition: Zn2+ interferes with the synthesis of peptidoglycan, the structural polymer that forms the bacterial cell wall. Without an intact cell wall, bacteria cannot maintain osmotic pressure and cannot divide.
Secondary action — Enzyme competition: Zn2+ competes with essential divalent metal cofactors (particularly Mg2+ and Mn2+) in bacterial enzymes. Many bacterial metabolic enzymes require these cofactors; Zn2+ displacement disrupts their catalytic function.
Zinc's MIC values are higher than silver's — approximately 5–15 ppm for S. aureus — which means higher loading is required. However, zinc oxide is significantly less expensive than silver-based carriers, and zinc ion is generally regarded as safer at trace levels for infant skin contact. The CN113650314A composition allows for a silver-zinc hybrid formulation that captures the potency of silver at lower total loading with zinc providing a broader baseline antimicrobial coverage.
Some lower-cost antimicrobial silicone products use organic biocides like triclosan or triclocarban. These are explicitly excluded from our formulation and should be on your restricted substance list. The US FDA banned triclosan from hand soaps in 2016 and has raised concerns about its presence in consumer products more broadly. Triclosan is an endocrine disruptor at levels well within what could leach from a poorly controlled antimicrobial compound into infant saliva. The EU restricts triclosan in cosmetics and personal care products. For an infant product, any organic biocide with hormone-disrupting potential is a non-starter.
ISO 22196 is titled "Measurement of antibacterial activity on plastics and other non-porous surfaces." It is the standard by which virtually all antibacterial surface claims are validated.
The test method:
A standard inoculum of 1.5–3.0 × 10^5 CFU/mL of test bacteria (typically S. aureus ATCC 6538 and E. coli ATCC 8739) is applied to the test surface
The surface is incubated under a polyethylene film cover at 35±1°C for 24 hours
After incubation, surviving bacteria are recovered, serially diluted, and plated
The antibacterial activity (R) is calculated as the log10 reduction in CFU compared to the uncoated control surface
A result of R ≥ 2.0 (99% reduction) is the minimum threshold for a meaningful antibacterial claim. Our CN113650314A composition achieves R ≥ 3.0 (99.9% reduction) against both S. aureus and E. coli under ISO 22196 conditions.
For context: a typical untreated platinum-cured silicone surface shows R = 0 (no antibacterial activity by ISO 22196). The test distinguishes between "the material does not actively kill bacteria" and "the material actively reduces bacterial populations."
A study published in Pediatrics found that pacifiers harbor measurable bacterial biofilms within 2 hours of use in a typical home environment. The dominant organisms were Staphylococcus species and Streptococcus species — exactly the organisms most commonly associated with infant oral infections.
Caregivers routinely "clean" pacifiers by sucking them — a practice that introduces adult oral flora including Streptococcus mutans (the primary cariogenic bacterium). While the health implications of this are debated, the surface hygiene concern is real. An antibacterial silicone surface does not eliminate the need for sterilization, but it reduces the bacterial load in the intervals between sterilization events.
Quantitatively: if a pacifier carries 10^4 CFU on its surface before being given to an infant, an antibacterial surface achieving R=3.0 reduces that to approximately 10 CFU over the 24-hour test period. Under real-use conditions (shorter contact, saliva dilution, variable temperature), the real-world reduction is lower — but the directional benefit is clear.
The composition in CN113650314A is specifically formulated for infant-contact applications. This means the antimicrobial agent loading is calibrated to be below:
EN 71-3 limits: Migration of category I elements (including silver and zinc) from toy materials. Zinc limit: 23,000 ppm (ABS material as comparator). Our formulation's zinc migration in EN 71-3 testing is <1,500 ppm. Silver limit under EN 71-3: 56 ppm. Our silver migration is <3 ppm.
FDA 21 CFR 177.2600: Total extractables under the chloroform extraction test. Our antimicrobial compound performs within the 0.5% limit.
Property | Silver Ion (Ag+) | Zinc Ion (Zn2+) |
Primary mechanism | Cell membrane disruption + respiratory enzyme inhibition | Cell wall synthesis inhibition |
MIC vs. S. aureus | 0.1–0.5 ppm | 5–15 ppm |
MIC vs. E. coli | 0.5–1.0 ppm | 8–20 ppm |
Speed of action | Fast (minutes for membrane disruption) | Moderate (hours for cell wall effect) |
Raw material cost | High (precious metal) | Low |
Discoloration risk in silicone | Low-moderate (managed by surface treatment) | Very low |
EN 71-3 migration limit | 56 ppm | 23,000 ppm |
Our migration result | <3 ppm | <1,500 ppm |
Best use case | Low-loading, high-potency formulations | Broad baseline coverage, cost-sensitive programs |
The CN113650314A composition uses both ions in a hybrid formulation, capturing the potency of silver at low loading with zinc providing broader baseline coverage against a wider pathogen spectrum.
"Can I just add silver nano-powder to my existing silicone compound?"
No — and this is exactly the gap the CN113650314A patent addresses. Silver nanoparticles without surface treatment agglomerate in silicone, create uneven antimicrobial performance, and may produce localized concentrations that exceed regulatory migration limits. You need the surface-treated, compatibilized particle that integrates into the silicone network.
"Does the antibacterial effect last?"
With the patent's surface-treatment bonding approach, yes — the antimicrobial agent is anchored in the silicone matrix rather than sitting on the surface. We have validated 30 dishwasher cycles with no significant reduction in R-value. Without the surface treatment, most competing formulations show R-value decline after 10–15 wash cycles.
"Is antibacterial silicone more expensive?"
The antimicrobial compound adds approximately 15–25% to raw material cost vs. standard infant-grade silicone. At typical pacifier unit economics, this translates to USD 0.08–0.15 per unit incremental cost. For a premium positioning strategy, the retail price premium from an "antibacterial" claim is typically 20–40% over standard silicone pacifiers — far exceeding the incremental manufacturing cost.
"What bacteria does it work against?"
ISO 22196 testing covers S. aureus and E. coli as the reference organisms. Our internal testing has also validated efficacy against Streptococcus mutans (the cariogenic bacterium) and Candida albicans (the organism responsible for oral thrush in infants). The latter two are the organisms most clinically relevant to infant oral health; we provide these extended test reports on request.
CN113650314A is an invention patent (not a utility model) granted by the China National Intellectual Property Administration. Invention patents in China require a full substantive examination and have a 20-year term from the filing date. The claims cover the antimicrobial silicone composition and its method of manufacture.
Mitour Silicone manufactures products using this technology for OEM clients. We do not separately license the patent to third-party manufacturers. If you want products manufactured using the CN113650314A composition, we are your manufacturer.
Ask for the ISO 22196 test report from an accredited lab. Verify the R-value (should be ≥ 2.0 minimum, ideally ≥ 3.0). Ask how many wash cycles the efficacy data covers. Ask for EN 71-3 migration test results for silver and zinc. If a supplier cannot provide all of this, the claim is not substantiated.
No. It reduces the bacterial load between sterilization events. Caregivers should still follow the manufacturer's sterilization guidance (microwave sterilization, dishwasher, or steam autoclave as validated for the product).
MOQ is 300 units on our standard mold base configurations. The antimicrobial compound requires a 1-week advance preparation cycle; factor this into your sampling and production timeline. Contact yfsalee@mymitour.com for a quote.
The surface-treatment bonding in the CN113650314A composition minimizes ion release under normal use conditions. Ion migration in our EN 71-3 testing is well below regulatory limits (silver <3 ppm vs. 56 ppm limit; zinc <1,500 ppm vs. 23,000 ppm limit). The ions are not freely released — they are bonded into the silicone network and exert their antimicrobial effect at the surface.
If you are developing an antibacterial silicone pacifier, teether, or other infant product line and want to use the technology covered by CN113650314A, reach out with your product brief.
Email: yfsalee@mymitour.com
Baby & childcare solutions: mymitour.com/solutions/baby-childcare.html
Materials overview: mymitour.com/oem-odm/materials.html
Certifications: mymitour.com/oem-odm/certifications.html
Baby & Childcare Solutions — contextual in clinical relevance section
Materials Overview — contextual in composition section
Certifications — contextual in ISO 22196 and EN 71-3 sections
Contact — CTA in Next Steps
By the Mitour Silicone team | 21 years of silicone manufacturing experience | 4,500 m² Shenzhen facility | Walmart-, Target-, and Disney-approved supplier | Contact: yfsalee@mymitour.com
